Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
Regulating Unapproved Drugs in the US: the Role of DESI and FDA Approval Pathways | Synapse
March 3, 2026
Regulating Unapproved Drugs in the US: the Role of DESI and FDA Approval Pathways
MR
M. Sukesh Rao
NS
N. S. Shetty
VH
Vignesh Hegde
Ver todo
Puntos clave
Regulatory pathways significantly influence the access and safety of unapproved drugs, ensuring public health.
The FDA approval process is crucial for assessing the efficacy and safety of medications before they reach patients.
DESI plays a vital role by evaluating older drugs that may not have undergone standard approval processes.
Understanding these regulatory frameworks is essential for improving drug availability and public health standards.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Rao et al. (Sat,) studied this question.
synapsesocial.com/papers/69a75a43c6e9836116a1fdb9
https://doi.org/https://doi.org/10.1007/s12247-025-10332-w
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir